Comparable stake leader
BlackRock, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001819576.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
5/50
Latest evidence
09 Oct 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
5 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
12%
Reported 13D/G
· 30 Jun 2026
|
$860,173,961
10,788,586 shares
|
— | 30 Jun 2026 |
| Farallon Capital Partners, L.P. |
13D/G
Dapice Joshua J.
|
9.9%
Reported 13D/G
· 31 Dec 2025
|
$316,810,991
8,656,038 shares
|
+$3,308,640 | 31 Dec 2025 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. |
13F
13D/G
Company
|
9.4%
Reported 13D/G
· 30 Jun 2026
|
$666,944,480
8,365,038 shares
|
— | 30 Jun 2026 |
| Paul B. Manning |
13D/G
3/4/5
Director
|
6.5%
Reported 13D/G
· 30 Jun 2026
|
$391,833,731
4,946,771 shares
|
$0 | 30 Jun 2026 |
| Legend Aggregator, LP |
13D/G
|
2.2%
Reported 13D/G
· 31 Dec 2024
|
$26,101,005
1,860,371 shares
|
$0 | 31 Dec 2024 |
| Caligan Partners LP |
13F
3/4/5
Company · Director, Other*, 10%+ Owner
|
—
mixed-class rows
|
$647,319,259
8,118,892 shares
|
— | 30 Jun 2026 |
| David Edward Johnson |
3/4/5
Director, 10%+ Owner
|
—
mixed-class rows
|
$388,997,597
19,464,533 shares
mixed-class rows
|
$0 | 16 Jun 2026 |
| FINDELL CAPITAL MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$279,223,390
3,502,112 shares
|
— | 30 Jun 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Net insider flow leans to selling over the last 12 months. Net value: -$230,357,964.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 566,853 | $0 | $25,763,747 | -$25,763,747 |
| 3-6 | 10,600 | 2,486,354 | $635,788 | $163,776,706 | -$163,140,918 |
| 6-9 | 0 | 767,605 | $0 | $29,624,942 | -$29,624,942 |
| 9-12 | 0 | 352,861 | $0 | $11,828,357 | -$11,828,357 |
Reporting owners
Showing 1-20 of 20 reporting-owner rows connected to Liquidia Corp. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| David Edward Johnson | Director, 10%+ Owner | $388,997,597 | $0 | 0% | Mixed | 16 Jun 2026 |
| Caligan Partners LP | Director, Other*, 10%+ Owner | $388,851,827 | $0 | 0% | Mixed | 16 Jun 2026 |
| Roger Jeffs | Chief Executive Officer, Director | $66,286,987 | -$32,182,294 | -33% | Mixed | 09 Oct 2026 |
| Paul B. Manning | Director | $25,432,155 | -$12,782,059 | -33% | Mixed | 16 Jun 2026 |
| Russell Schundler | General Counsel | $18,960,489 | -$3,057,983 | -14% | Mixed | 09 Oct 2026 |
| Michael Kaseta | CFO and COO | $11,161,008 | -$16,238,139 | -59% | Mixed | 09 Oct 2026 |
| Jason Adair | Chief Business Officer | $8,807,836 | -$7,906,020 | -47% | Mixed | 26 Oct 2026 |
| Dana Boyle | Chief Accounting Officer | $7,084,369 | -$2,505,474 | -26% | Filing P/S | 26 Oct 2026 |
| Scott Moomaw | Chief Commercial Officer | $6,106,032 | -$5,659,128 | -48% | Mixed | 09 Oct 2026 |
| Dr. Rajeev Saggar | Chief Medical Officer | $4,901,431 | -$11,300,788 | -70% | Mixed | 09 Oct 2026 |
| Damian deGoa | Director | $3,485,402 | Mixed | 16 Jun 2026 | ||
| Sarah Krepp | Chief Human Resource Officer | $3,282,063 | -$3,796,721 | -54% | Filing P/S | 09 Oct 2026 |
| Katherine Rielly-Gauvin | Director | $3,224,009 | -$4,087,435 | -56% | Filing P/S | 19 Aug 2026 |
| Dr. Stephen M. Bloch | Director | $3,164,434 | -$125,050,198 | -98% | Median | 05 Oct 2026 |
| Raman Singh | Director | $2,953,183 | -$3,673,716 | -55% | Filing P/S | 11 Sep 2026 |
| Sanjeev Khindri | Chief Development Officer | $1,846,814 | -$386,708 | -17% | Filing P/S | 12 Oct 2026 |
| Arthur S. Kirsch | Director | $1,760,080 | -$1,731,300 | -50% | Mixed | 16 Jun 2026 |
| Robert A. Lippe | Chief Operations Officer | $1,606,948 | Mixed | 30 Nov 2023 | ||
| Dr. Joanna Horobin | Director | $1,495,900 | Mixed | 16 Jun 2026 | ||
| Dr. Tushar Shah | CMO and Head of R&D | $259,700 | Mixed | 16 Jan 2022 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Dana Boyle | LQDA | Common Stock | Sale | -0.95% | -$68,283 | $43.19 | -1,581 | 164,028 | 26 Oct 2026 | Direct |
| Jason Adair | LQDA | Common Stock | Sale | -0.39% | -$29,715 | $43.19 | -688 | 177,269 | 26 Oct 2026 | Direct |
| Russell Schundler | LQDA | Common Stock | Sale | -2.22% | -$389,948 | $28.48 | -13,692 | 602,841 | 12 Oct 2026 | Direct |
| Dr. Rajeev Saggar | LQDA | Common Stock | Sale | -6.8% | -$262,529 | $28.48 | -9,218 | 126,368 | 12 Oct 2026 | Direct |
| Scott Moomaw | LQDA | Common Stock | Sale | -4.66% | -$252,418 | $28.48 | -8,863 | 181,487 | 12 Oct 2026 | Direct |
| Sarah Krepp | LQDA | Common Stock | Sale | -4.35% | -$149,378 | $28.48 | -5,245 | 115,241 | 12 Oct 2026 | Direct |
| Sanjeev Khindri | LQDA | Common Stock | Sale | -1.67% | -$31,356 | $28.48 | -1,101 | 64,846 | 12 Oct 2026 | Direct |
| Michael Kaseta | LQDA | Common Stock | Sale | -5.27% | -$539,354 | $28.48 | -18,938 | 340,148 | 12 Oct 2026 | Direct |
| Roger Jeffs | LQDA | Common Stock | Sale | -2.83% | -$932,549 | $28.48 | -32,744 | 1,125,848 | 12 Oct 2026 | Direct |
| Dana Boyle | LQDA | Common Stock | Sale | -3.44% | -$167,804 | $28.48 | -5,892 | 165,609 | 12 Oct 2026 | Direct |
| Jason Adair | LQDA | Common Stock | Sale | -3.94% | -$207,932 | $28.48 | -7,301 | 177,957 | 12 Oct 2026 | Direct |
| Russell Schundler | LQDA | Common Stock | Options Exercise | 1.68% | 10,167 | 616,533 | 09 Oct 2026 | Direct | ||
| Russell Schundler | LQDA | Performance Stock Units | Options Exercise | -35.1% | -10,167 | 18,792 | 09 Oct 2026 | Direct | ||
| Dr. Rajeev Saggar | LQDA | Common Stock | Options Exercise | 6.28% | 8,016 | 135,586 | 09 Oct 2026 | Direct | ||
| Dr. Rajeev Saggar | LQDA | Performance Stock Units | Options Exercise | -31.2% | -8,016 | 17,654 | 09 Oct 2026 | Direct | ||
| Scott Moomaw | LQDA | Common Stock | Options Exercise | 4.08% | 7,466 | 190,350 | 09 Oct 2026 | Direct | ||
| Scott Moomaw | LQDA | Performance Stock Units | Options Exercise | -32.5% | -7,466 | 15,538 | 09 Oct 2026 | Direct | ||
| Sarah Krepp | LQDA | Common Stock | Options Exercise | 2.71% | 3,178 | 120,486 | 09 Oct 2026 | Direct | ||
| Sarah Krepp | LQDA | Performance Stock Units | Options Exercise | -10% | -3,178 | 28,609 | 09 Oct 2026 | Direct | ||
| Michael Kaseta | LQDA | Common Stock | Options Exercise | 3.72% | 12,877 | 359,086 | 09 Oct 2026 | Direct | ||
| Michael Kaseta | LQDA | Performance Stock Units | Options Exercise | -30.6% | -12,877 | 29,140 | 09 Oct 2026 | Direct | ||
| Roger Jeffs | LQDA | Common Stock | Options Exercise | 2.49% | 28,166 | 1,158,592 | 09 Oct 2026 | Direct | ||
| Roger Jeffs | LQDA | Performance Stock Units | Options Exercise | -28.9% | -28,166 | 69,168 | 09 Oct 2026 | Direct | ||
| Dana Boyle | LQDA | Common Stock | Options Exercise | 1.89% | 3,178 | 171,501 | 09 Oct 2026 | Direct | ||
| Dana Boyle | LQDA | Performance Stock Units | Options Exercise | -10% | -3,178 | 28,609 | 09 Oct 2026 | Direct | ||
| Jason Adair | LQDA | Common Stock | Options Exercise | 5.86% | 10,248 | 185,258 | 09 Oct 2026 | Direct | ||
| Jason Adair | LQDA | Performance Stock Units | Options Exercise | -33.9% | -6,342 | 12,371 | 09 Oct 2026 | Direct | ||
| Jason Adair | LQDA | Restricted Stock Units | Options Exercise | -50% | -3,906 | 3,906 | 09 Oct 2026 | Direct | ||
| Dr. Stephen M. Bloch | LQDA | Common Stock | Sale | -100% | -$6,387,596 | $27.13 | -235,477 | 0 | 05 Oct 2026 | See footnote |
| Raman Singh | LQDA | Common Stock | Sale | -16% | -$560,243 | $66.16 | -8,468 | 44,637 | 14 Sep 2026 | Direct |
| Raman Singh | LQDA | Common Stock | Options Exercise | 19% | 8,468 | 53,105 | 14 Sep 2026 | Direct | ||
| Raman Singh | LQDA | Non-Qualified Stock Option (right to buy) | Options Exercise | -100% | -8,468 | 0 | 14 Sep 2026 | Direct | ||
| Raman Singh | LQDA | Common Stock | Sale | -16.8% | -$619,210 | $68.62 | -9,024 | 44,637 | 11 Sep 2026 | Direct |
| Raman Singh | LQDA | Common Stock | Options Exercise | 20.2% | 9,024 | 53,661 | 11 Sep 2026 | Direct | ||
| Raman Singh | LQDA | Non-Qualified Stock Option (right to buy) | Options Exercise | -100% | -9,024 | 0 | 11 Sep 2026 | Direct | ||
| Sarah Krepp | LQDA | Common Stock | Sale | -0.23% | -$18,566 | $67.76 | -274 | 117,308 | 01 Sep 2026 | Direct |
| Jason Adair | LQDA | Common Stock | Sale | -29.7% | -$5,087,225 | $69.09 | -73,631 | 174,606 | 21 Aug 2026 | Direct |
| Jason Adair | LQDA | Common Stock | Options Exercise | 14.7% | 31,799 | 248,237 | 21 Aug 2026 | Direct | ||
| Jason Adair | LQDA | Incentive Stock Option (right to buy) | Options Exercise | -100% | -22,561 | 0 | 21 Aug 2026 | Direct | ||
| Jason Adair | LQDA | Non-Qualified Stock Option (right to buy) | Options Exercise | -100% | -9,238 | 0 | 21 Aug 2026 | Direct | ||
| Katherine Rielly-Gauvin | LQDA | Common Stock | Sale | -29.2% | -$1,328,477 | $72.23 | -18,393 | 44,637 | 20 Aug 2026 | Direct |
| Katherine Rielly-Gauvin | LQDA | Common Stock | Options Exercise | 41.2% | 18,393 | 63,030 | 20 Aug 2026 | Direct | ||
| Katherine Rielly-Gauvin | LQDA | Non-Qualified Stock Option (right to buy) | Options Exercise | -100% | -18,393 | 0 | 20 Aug 2026 | Direct | ||
| Katherine Rielly-Gauvin | LQDA | Common Stock | Sale | -45.2% | -$2,758,958 | $74.99 | -36,789 | 44,637 | 19 Aug 2026 | Direct |
| Katherine Rielly-Gauvin | LQDA | Common Stock | Options Exercise | 82.4% | 36,789 | 81,426 | 19 Aug 2026 | Direct | ||
| Katherine Rielly-Gauvin | LQDA | Non-Qualified Stock Option (right to buy) | Options Exercise | -84.7% | -36,789 | 6,666 | 19 Aug 2026 | Direct | ||
| Dr. Rajeev Saggar | LQDA | Common Stock | Sale | -26% | -$3,702,825 | $74.06 | -50,000 | 142,265 | 19 Aug 2026 | Direct |
| Dr. Rajeev Saggar | LQDA | Common Stock | Options Exercise | 35.2% | 50,000 | 192,265 | 19 Aug 2026 | Direct | ||
| Dr. Rajeev Saggar | LQDA | Non-Qualified Stock Option (right to buy) | Options Exercise | -25% | -50,000 | 150,000 | 19 Aug 2026 | Direct | ||
| Dr. Rajeev Saggar | LQDA | Common Stock | Sale | -17.2% | -$2,269,381 | $76.84 | -29,534 | 142,265 | 17 Aug 2026 | Direct |